What Percentage of People Lose Weight on Mounjaro?

Last reviewed: July 12, 2026

Last updated: July 12, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide represents a significant advancement in weight management because it activates two hormone pathways—GLP-1 and GIP—rather than one. Clinical data demonstrates that most people taking tirzepatide experience measurable weight reduction, though individual results depend on factors like baseline metabolism, lifestyle adherence, and genetic predisposition to peptide sensitivity.

Clinical Trial Weight Loss Rates for Tirzepatide

Phase 3 trials for tirzepatide showed that approximately 85-90% of participants achieved clinically significant weight loss compared to placebo. In the SURMOUNT program, patients on the highest tirzepatide doses lost between 20-22% of their body weight over 68 weeks, substantially exceeding results from earlier single-hormone GLP-1 medications. These outcomes reflect tirzepatide's dual-mechanism approach to appetite regulation and metabolic control.

Response variability exists within these overall success rates. Some patients experience rapid weight reduction within the first 8-12 weeks, while others show more gradual progress over 4-6 months. Individual factors including starting weight, age, insulin sensitivity status, and adherence to dosing schedules significantly influence the timeline and magnitude of weight loss observed in real-world practice.

Why Tirzepatide Produces Weight Loss in Most Patients

Tirzepatide works by stimulating GLP-1 and GIP receptors in the brain's appetite-regulation centers. This dual activation increases satiety signals, reduces hunger hormone production, and slows gastric emptying—creating a sustained feeling of fullness that makes calorie reduction achievable without willpower alone. The combination approach proves more effective than single-pathway medications for a broader population of people struggling with weight management.

Beyond appetite suppression, tirzepatide influences glucose metabolism and insulin sensitivity at the cellular level. Improved metabolic function can accelerate fat loss while preserving lean muscle tissue, which explains why tirzepatide users often report sustained energy levels despite reduced caloric intake. This metabolic benefit contributes to the high percentage of people experiencing both weight loss and improved overall health markers.

Genetic Factors That Influence Tirzepatide Response

The PlexusDx Precision Peptide Genetic Test analyzes GLP1R, GIPR, and FTO (rs9939609) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

PlexusDx offers the Precision Peptide Genetic Test, a peptide-pathway analysis that examines 14 biological pathways, 49 peptides, and 150+ genetic insights relevant to GLP-1 and tirzepatide effectiveness. This test—available for $99 after starting treatment—enables your provider to anticipate your individual response pattern and adjust your protocol proactively, rather than relying on trial-and-error dosing. Patients with data-driven personalization often achieve better outcomes than those following standard protocols alone.

PlexusDx Compounded Tirzepatide vs. Brand-Name Mounjaro

PlexusDx sources compounded tirzepatide from licensed 503A compounding pharmacies, delivering the same active pharmaceutical ingredient as brand-name Mounjaro at a significantly lower cost. Compounded tirzepatide begins at $289 per month across all dose levels—your dose may need to go up, but your price won't. This pricing model removes the financial barrier that prevents many eligible candidates from accessing tirzepatide therapy.

Both compounded and brand-name tirzepatide produce comparable weight loss outcomes because the active molecule remains identical. The difference lies in accessibility: PlexusDx serves all 50 states without requiring insurance, membership fees, or prior authorization delays. Patients can begin tirzepatide therapy within days rather than weeks, maximizing the window for sustained weight loss momentum and metabolic improvement.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What percentage of people actually lose weight while taking tirzepatide?

Clinical trials demonstrate that 85-90% of tirzepatide users achieve measurable weight loss, with most patients losing 15-22% of their starting body weight within 6 months. Individual results vary based on genetics, baseline metabolism, and treatment adherence, but the majority experience clinically significant reductions in body weight and improvements in metabolic markers.

How does tirzepatide weight loss compare to other GLP-1 medications?

Tirzepatide produces superior outcomes compared to single-pathway GLP-1 medications because it activates both GLP-1 and GIP receptors simultaneously. Clinical data shows tirzepatide users lose approximately 20-22% of body weight versus 15-17% for semaglutide, making the dual-hormone approach more effective for a broader population of patients.

How much does tirzepatide cost at PlexusDx?

PlexusDx compounded tirzepatide injection begins at $289/mo (or $249/mo on the 6-month plan) with no dose-dependent price increases—your dose may go up, but your price won't. PlexusDx serves all 50 states without insurance requirements and qualifies for HSA/FSA accounts, making tirzepatide accessible regardless of insurance status.

Are there any reasons someone might not lose weight on tirzepatide?

While 85-90% of users experience weight loss, non-responders typically have specific genetic variants limiting GLP-1 or GIP receptor efficiency. Other factors include inadequate dosing, poor medication adherence, significant caloric overeating, unmanaged thyroid disorders, or certain hormonal imbalances. The Precision Peptide Genetic Test can identify genetic limitations early, enabling your provider to consider combination protocols like GLP-Squared (tirzepatide plus semaglutide) for enhanced results.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

Yes—PlexusDx's Precision Peptide Genetic Test analyzes key variants including GLP1R rs6923761 and GIPR rs1800437, which directly influence tirzepatide responsiveness across 14 pathways and 49 peptides. This $99 test (available after first month of treatment) provides personalized insights into your genetic predisposition to medication response, enabling your provider to optimize dosing, anticipate timeline, and recommend combination therapy if needed for maximum weight loss results.

Related Reading

• Mounjaro For Losing Weight
• Mounjaro For Weight Loss 2
• Weight Loss Mounjaro
• Mounjaro Weight Loss By Week

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.